The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.EBI
Momenta Pharmaceuticals
Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches.EBI
Centro De Investigaci�N Pr�Ncipe Felipe
QSAR study of heparanase inhibitors activity using artificial neural networks and Levenberg-Marquardt algorithm.EBI
Sharif University of Technology
Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis.EBI
Progen Pharmaceuticals
Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.EBI
Progen Pharmaceuticals
Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88.EBI
Progen Pharmaceuticals
Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.EBI
Emory University
Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.EBI
Shandong University
The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance.EBI
Guangzhou University of Chinese Medicine
Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.EBI
Guangzhou University of Chinese Medicine
Lead identification of novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent heparanase-1 inhibitor.EBI
Taisho Pharmaceutical Co.
Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).EBI
Progen Industries
1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.EBI
Imclone Systems
N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.EBI
Imclone Systems
Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor.EBI
Celltech R&D
2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors.EBI
Celltech R&D
Rational design and synthesis of novel heparan sulfate mimetic compounds as antiadhesive agents.EBI
Riken Discovery Research Institute
Modulating Heparanase Activity: Tuning Sulfation Pattern and Glycosidic Linkage of Oligosaccharides.EBI
Wayne State University
Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.EBI
"Sapienza" Universit£
Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.EBI
"Sapienza" Universit£
Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.EBI
Universit£
Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.EBI
University of Ferrara